Avient Corporation (NYSE: AVNT) reported Q4 EPS of $0.52, $0.07 better than the analyst estimate of $0.45. Revenue for the quarter came in at $997 million versus the consensus estimate of $922.93 million.

GUIDANCE:

Avient Corporation sees FY2021 EPS of $1.93-$2.40, versus the consensus of $2.31.

• Commenting on the Company's 2021 outlook, Mr. Patterson said, "As the COVID-19 vaccine brings hope for a recovery from the pandemic, we anticipate our businesses will continue to benefit from new product development requiring sustainable solutions as well as demand for consumer and healthcare applications. We will also uniquely benefit from the Clariant Masterbatch acquisition and related synergy capture, which is well ahead of schedule."
• Mr. Patterson added, "We will provide more details on our upcoming webcast, but our headline projection for 2021 is that we expect revenue growth of approximately 8% pro forma will drive adjusted EPS expansion from $1.93 to $2.40 - an increase of 24%."
• The Company noted it will provide more details on its 2021 outlook during the webcast scheduled for 9:00 a.m. Eastern Time on February 9, 2021.

For earnings history and earnings-related data on Avient Corporation (AVNT) click here.